Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

The Kenya tuberculosis diagnostics market was valued at USD 138.43 Million in 2025 and is expected to grow at a CAGR of 4.40%, reaching USD 212.93 Million by 2035. The market growth is driven by the high burden of tuberculosis, government investment in the national strategic plan, growing initiatives, and growing demand for drug-resistant TB testing.

Key Market Trends and Insights

  • By diagnostics, molecular diagnostics are likely to lead market in the forecast period.
  • By disease type, latent tuberculosis diagnostics held nearly 40% of the market in the historical period.
  • By end user, diagnostic labs segment led the market in the historical period.

Market Size and Forecast

  • Market Size (2025): USD 138.43 Million
  • Projected Market Size (2035): USD 212.93 Million
  • CAGR (2026-2035): 4.40%

Compound Annual Growth Rate

4.4%

Value in USD Million

2026-2035


Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Kenya Tuberculosis Diagnostics Market Overview

Tuberculosis (TB) diagnostics refers to the range of laboratory tests, imaging techniques, and molecular assays used to detect Mycobacterium tuberculosis, the bacterium responsible for tuberculosis, determine the presence of active TB disease, and identify drug resistance to guide appropriate treatment. The market was valued at USD 138.43 Million in 2025, driven by the high burden of tuberculosis, increasing government investment in TB control programmes, expansion of molecular diagnostic testing, and efforts to improve early case detection and treatment initiation.

Kenya Tuberculosis Diagnostics Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

Expansion of decentralized molecular testing and AI-enabled diagnostic infrastructure

In June 2026, Kiambu County received over KSh 20 million in TB diagnostic equipment, including portable molecular testing technologies and a digital AI stethoscope.

Market Restraints

Dependence on external funding and persistent gaps in domestic tuberculosis diagnostic financing

In March 2025, Kenya's Ministry of Health reported GeneXpert cartridge shortages following a temporary suspension of US funding.

Market Opportunities

Expansion of near-point-of-care molecular testing across underserved and remote healthcare facilities

In September 2026, the Global Fund selected Kenya among 13 countries for nearly 3 million portable molecular TB tests by the end of 2026.

Kenya Tuberculosis Diagnostics Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Kenya Tuberculosis Diagnostics Market Growth Drivers

Expansion of Decentralized Testing and AI-Enabled Diagnostic Technologies to Boost the Market Value

The expansion of decentralized molecular testing is strengthening the market by improving access to rapid testing closer to patients. In June 2026, Kiambu County received TB diagnostic equipment worth over KSh 20 million under the NPOC ACCESS initiative, introducing portable molecular testing and a digital AI stethoscope. Additionally, the Global Fund included Kenya among 13 countries selected for the rollout of nearly 3 million near-point-of-care TB tests. These initiatives support diagnostic accessibility and decentralized testing.

Kenya Tuberculosis Diagnostics Market Restraints

Donor Dependence and Persistent Diagnostic Financing Gaps to Limit Market Expansion

The market faces financing constraints due to dependence on external donors and inadequate domestic healthcare allocations. In March 2025, Kenya's Ministry of Health reported supply gaps in GeneXpert cartridges following a temporary suspension of US funding. In September 2026, Daily Nation reported a Sh4.5 billion national TB funding shortfall, highlighting challenges affecting screening access and digital X-ray licensing. These financing limitations threaten procurement continuity, diagnostic infrastructure utilization, and sustainable market expansion.

Kenya Tuberculosis Diagnostics Market Opportunities

Expansion of Decentralized Molecular Testing is Likely to Enhance the Market Landscape

The market presents opportunities to expand decentralized molecular testing and improve access to diagnosis in underserved communities. In September 2026, the Global Fund announced that Kenya was among 13 countries selected to roll out nearly 3 million near-point-of-care molecular TB tests by the end of 2026. These portable tests are intended for primary healthcare centers and remote settings, potentially reducing reliance on complex laboratory infrastructure and strengthening diagnostic access across Kenya.

Kenya Tuberculosis Diagnostics Market Trends

The market is witnessing several key trends, including a shift toward decentralized molecular testing, the adoption of advanced diagnostic technologies, and the integration of AI-enabled screening solutions.

Shift Towards Decentralized Molecular Testing and AI-Enabled Screening to Elevate the Market Growth

The market is witnessing a shift toward decentralized testing and advanced screening technologies to improve early disease detection. InMarch 2026, Kenya’s Ministry of Health reported expanding TB services across all 47 counties through the deployment of molecular diagnostic technologies and ultraportable AI-enabled digital X-ray machines. These initiatives are strengthening diagnostic accessibility, particularly in remote areas, and supporting demand for portable molecular testing platforms and AI-assisted screening solutions.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Kenya Tuberculosis Diagnostics Market Share

Molecular Diagnostics are most Likely to Lead the Market by Diagnostics

Molecular diagnostics are gaining importance in the market, supported by government initiatives to improve early detection and expand access to diagnostic services. In March 2026, Kenya’s Ministry of Health reported expanding TB services across all 47 counties through the deployment of molecular diagnostic technologies and AI-enabled digital X-ray machines. The expansion is expected to strengthen diagnostic accessibility, improve case detection, and support timely identification of tuberculosis, reinforcing demand for molecular diagnostic solutions in Kenya.

Leading Players in the Kenya Tuberculosis Diagnostics Market

The key features of the market report include strategic initiatives by leading players. The major companies in the market are as follows:

Qiagen N.V.

Qiagen is a global molecular diagnostics and life sciences company specializing in sample preparation, nucleic acid extraction and molecular testing technologies. Its tuberculosis diagnostic portfolio includes QuantiFERON-TB Gold Plus, an interferon-gamma release assay used to identify TB infection, and technologies supporting molecular detection and laboratory-based infectious disease testing. The company serves clinical laboratories, hospitals and research institutions worldwide.

Cepheid

Cepheid, a subsidiary of Danaher Corporation, develops automated molecular diagnostic systems for infectious disease detection. Its GeneXpert platform and Xpert MTB/RIF and Xpert MTB/RIF Ultra assays enable rapid detection of Mycobacterium tuberculosis and rifampicin resistance. The company's cartridge-based testing technology supports decentralized diagnostics.

Eiken Chemical Co., Ltd.

Eiken Chemical is a Japanese diagnostics manufacturer specializing in clinical laboratory testing, molecular diagnostics and microbiological assays. Its tuberculosis diagnostic portfolio includes the Loopamp MTBC Detection Kit, which uses loop-mediated isothermal amplification (LAMP) technology to detect Mycobacterium tuberculosis. Its technologies support simplified molecular testing and contribute to expanding TB diagnostic capabilities in resource-limited healthcare settings.

Qure.ai Technologies Private Limited

Qure.ai is an artificial intelligence healthcare technology company specializing in medical imaging analysis and clinical decision-support solutions. Its qXR platform uses AI algorithms to analyze chest X-rays and identify abnormalities associated with pulmonary tuberculosis. The technology supports large-scale screening, automated triage, and earlier identification of suspected TB cases, particularly in high-burden and resource-constrained healthcare settings.

Other key players in the market include Abbott, Becton, Dickinson and Company (BD), FUJIFILM Holdings Corporation, Molbio Diagnostics Private Limited, F. Hoffmann-La Roche Ltd., and Hain Lifescience GmbH.

*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*

Kenya Tuberculosis Diagnostics Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Diagnostics

  • Molecular Diagnostics
  • Sputum Smear Microscopy
  • Culture-Based Diagnostics
  • Immunological and Antigen-Based Tests
  • Drug Susceptibility Testing

The segment is supported by the increasing adoption of rapid nucleic acid amplification tests for detecting Mycobacterium tuberculosis and rifampicin resistance. Government-led expansion of diagnostic networks, demand for early case identification, and international funding for TB control are strengthening molecular testing accessibility across Kenya.

Market Breakup by Disease Type

  • Pulmonary Tuberculosis Diagnostics
  • Extrapulmonary Tuberculosis Diagnostics
  • Latent Tuberculosis Diagnostics Infection

Pulmonary tuberculosis diagnostics account for substantial testing demand because pulmonary TB represents the predominant disease presentation and remains central to community screening and case detection programmes. Increasing deployment of sputum-based molecular assays, microscopy and chest radiography is supporting diagnosis, while improved clinical evaluation and specimen-based testing are strengthening detection of extrapulmonary and latent TB infections.

Market Breakup by End User

  • Hospitals
  • Diagnostic Labs
  • Research Laboratories
  • Others

Hospitals represent an important end-user segment owing to their role in TB screening, clinical diagnosis, treatment initiation, and management of drug-resistant infections. Increasing availability of molecular diagnostic platforms, laboratory infrastructure investments and integrated TB/HIV services are supporting hospital-based testing. Diagnostic laboratories and public health facilities further contribute through confirmatory testing and surveillance activities.

Key Questions Answered in the Kenya Tuberculosis Diagnostics Market Report

  • What was the Kenya tuberculosis diagnostics market value in 2025?
  • What is the Kenya tuberculosis diagnostics market forecast outlook for 2026-2035?
  • What are the major factors aiding the Kenya tuberculosis diagnostics market demand?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major Kenya tuberculosis diagnostics market trends?
  • Which diagnostics is expected to dominate the market segment?
  • Which disease type is projected to lead the market segment?
  • Which end user is anticipated to drive the market segment?
  • Who are the key players involved in the Kenya tuberculosis diagnostics market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

Research Methodology

This report is developed through a structured research approach combining secondary research, market assessment, and data validation:

  • Primary Research: The research framework considers insights from tuberculosis specialists, healthcare providers, diagnostic laboratory professionals, procurement stakeholders, and public health experts to assess diagnostic adoption, testing accessibility, infrastructure requirements, and market challenges in Kenya.
  • Secondary Research: The study incorporates information from Kenya’s Ministry of Health, the Global Fund, and Daily Nation to evaluate national TB control initiatives, diagnostic funding, equipment deployment, and molecular testing expansion. Company websites and product portfolios of QIAGEN, Cepheid, Eiken Chemical, Qure.ai, Abbott, and other key players support the competitive landscape and technology assessment.
  • Validation: Qualitative findings are cross-checked against available institutional announcements, company information, and supporting publications. Market assessments are reviewed using structured top-down and bottom-up analytical approaches.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

REPORT FEATURES DETAILS
Base Year 2025
Historical Period 2019-2025
Forecast Period 2026-2035
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Diagnostics
  • Disease Type
  • End User
Breakup by Diagnostics
  • Molecular Diagnostics
  • Sputum Smear Microscopy
  • Culture-Based Diagnostics
  • Immunological & Antigen-Based Tests
  • Drug Susceptibility Testing
Breakup by Disease Type
  • Pulmonary Tuberculosis Diagnostics
  • Extrapulmonary Tuberculosis Diagnostics
  • Latent Tuberculosis Diagnostics Infection
Breakup by End User
  • Hospitals
  • Diagnostic Labs
  • Research Laboratories
  • Others
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • PESTEL Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Company News and Developments
    • Certifications
Companies Covered
  • Abbott
  • Becton, Dickinson and Company (BD)
  • Qiagen N.V.
  • FUJIFILM Holdings Corporation
  • Cepheid
  • Molbio Diagnostics Private Limited
  • Hain Lifescience GmbH
  • Eiken Chemical Co., Ltd.
  • Qure.ai Technologies Private Limited
  • F. Hoffmann-La Roche Ltd.

Datasheet

10 % Off

USD

1,999

1,799

Single User License

10 % Off

USD

3,099

2,789

Five User License

15 % Off

USD

4,599

3,909

Corporate License

15 % Off

USD

5,999

5,099

Datasheet

One User

USD 1,999

USD 1,799

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 3,099

USD 2,789

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 4,599

USD 3,909

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 5,999

USD 5,099

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us